|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||0.0067 - 0.0080|
|52 Week Range||0.0067 - 0.2000|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
PALATKA, FL, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Majestic Holdings, Inc. (MJOG) (“Majestic" or the “Company"), based on the results of Tuesday’s election, it’s just a matter of time before marijuana will become legal in all 50 states. This marks the first year that sales of hemp-derived CBD products outpaced marijuana-derived CBD products. With the legalization efforts in Michigan, Missouri, and Utah being successful from Tuesday’s election and yesterday’s announcement that Jeff Sessions has resigned from his post, the cannabis and CBD sector is poised to take off after a slight pullback after the Canadian legalization and run up to the midterm elections.
PALATKA, FL, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Majestic Holdings, Inc. (MJOG) (“Majestic" or the “Company"), is pleased to announce that it has begun discussions regarding a joint venture with a prominent hemp grower based in Rhode Island. As part of the agreement, Majestic will manage the grower and processor’s outdoor industrial hemp plants, as well as extraction, bottling, and packaging facilities. The global industrial hemp market size is expected to reach $10.6 billion by 2025, according to a recent report by Grand View Research, Inc. The U.S. CBD market is primed for expansive growth for both hemp-derived CBD and marijuana-derived CBD.
PALATKA, FL, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Majestic Oil & Gas, Inc. (MJOG) (the “Company") will be entering the emerging Cannabidiol market through MJ Biotech Inc., a subsidiary focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields. With the recent announcement by the U.S. Drug Enforcement Administration, of removing cannabidiol (CBD) off the most restrictive class of controlled substances, a move that allows the sale of cannabis-derived medicine to win federal approval. “As previously announced MJOG, through its subsidiary MJ Biotech, will look to focus on Biotech, healthcare, and the nutracuetical market. Now with the published medicinal benefits of CBD and its many helpful benefits, and we are excited for the new changes made by the DEA.